FDAPart D/Prescription Drugs

Gone With A Shot? Hopeful New Signs Of Relief For Migraine Sufferers

(By Lauren Gravitz for NPR)

Humans have suffered from migraines for millennia. Yet, despite decades of research, there isn’t a drug on the market today that prevents them by targeting the underlying cause. All of that could change in a few months when the FDA is expected to announce its decision about new therapies that have the potential to turn migraine treatment on its head. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply